The advertisement promotes the ENROUTE Transcarotid Neuroprotection System by Boston Scientific, highlighting its impact on patient lives and encouraging exploration of the TCAR procedure.
Creative Information
| CID: | 25a3ed69-bcef-49ec-a48e-1f6aafb30d4b |
| CRID: | 2_206_490149 |
| Domain: | bostonscientific.com |
| Seat: | BSW |
| Size: | 300x250 |
| Bid: | $1.34 |
| Timestamp: | 10/31/2025, 5:35:04 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 5:53:43 PM | 5.34s | |
| adomain_analysis | success | 10/31/2025, 5:53:26 PM | 4.35s | |
| adomain_capture | success | 10/31/2025, 5:53:22 PM | 0.20s | |
| ad_render | success | 10/31/2025, 5:53:37 PM | 16.80s | |
| brand_mapping | success | 10/31/2025, 5:35:05 PM | 0.13s | |
Analysis Results
Ad Format: banner
Brands: Boston Scientific
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 886.92 KB | ||||||||||||||||||||||
| Render Time: | 7.96 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 906.09 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Raw Ad Markup
<script src="https://tagan.adlightning.com/iponweb/blacklist_script.js" type="text/javascript"></script>
<script src="https://tagan.adlightning.com/iponweb/blocking_script.js" type="text/javascript"></script>
<script type="text/javascript">
function createTagDetails(){
var tagDetails = {};
tagDetails.w = '300';
tagDetails.h = '250';
tagDetails.adServerDetails = {advertiserId: 'kargo', campaignId: '206', creativeId: '206_490149', lineitemId: '0', adServer: 'dfp'};
tagDetails.au = '0';
tagDetails.markupInDom = true;
tagDetails.utilizeParentInfo = true;
var timeBase36 = Date.now().toString(36);
var random = Math.random().toString(36).substr(2).split('')
.map(function (c) {
return (Math.random() < 0.5 ? c.toUpperCase() : c); }) .join('');
tagDetails.currentTagId="adltag_" + timeBase36 + "_" + random;
return tagDetails;
}
var random = "" + Math.round(Math.random() * 1e8);
var clientId = "iponweb";
var site_id = random + "_" + clientId;
window[site_id]={};
window[site_id].tagDetails=createTagDetails();
!function(){"use strict";"blocker"in window||(window.blocker=function(e,n,o,i,t){if((t=t||{}).bw){if(Math.random()<.1){var r="undefined"!=typeof btoa?btoa:String,a="https://"+clientId+"-tagan.adlightning.com",d={siteId:clientId,url:window.top.location.href,tagDetails:window[e],errorData:null,errorMethod:"missing_blocker"},c=encodeURIComponent(JSON.stringify(d)).replace(/%([0-9A-F]{2})/g,function(e,n){return String.fromCharCode("0x"+n)});!function(e){var n=window.Request,o=n&&n.prototype||{};if(navigator&&navigator.sendBeacon)navigator.sendBeacon(e);else if(window.fetch){var i={method:"GET"};"keepalive"in o&&(i.keepalive=!0),window.fetch(e,i)}else{var t=new Image(1,1);"loading"in t&&(t.loading="eager"),t.src=e}}(a+"/error?d="+encodeURIComponent(r(c)))}document.write(n)}})}();
blocker(site_id, "<!--ADL_WRAPPED-->", false, window, {fr: true});
</script>
<ins class='dcmads' style='display:inline-block;width:300px;height:250px' data-dcm-placement='N1991638.2055741ADTHEORANT/B33614802.421061219' data-dcm-rendering-mode='script' data-dcm-https-only data-dcm-keywords='fd181b52-b40f-11f0-a366-1249d22f96b3' data-dcm-click-tracker='https%3A%2F%2Frtb.adentifi.com%2FClicks%3FcrId%3D490149%3BsId%3D772807%3BlId%3D103491%3BcId%3D19716%3BadExchange%3DBidSwitch%3Baction%3Dclick%3BadId%3Dfd181b52-b40f-11f0-a366-1249d22f96b3%3BadThdId%3Dd40443e7ac16c6af7659e34a6130da83%3BengineId%3Di-01fe4a2c5dab46173%3BdIp%3DNTAuMTcwLjIwMC40Mg%3BdIpv6%3D%3BadThdIdCode%3DWEB_MD5_V4%3BdealId%3D0%3BgeoId%3D111875%3BinventoryId%3D223217%3BrtdmIndicator%3D1%3Btimestamp%3D1761664121%3Blat%3DNDIuMzk%3Blong%3DLTcxLjEz%3Bdma%3DNTA2%3BstateCode%3D%3Bzip%3DMDIxNDA%3Bbsc%3D${CLICK_URL_ENC}%3Bredir%3D' data-dcm-resettable-device-id='' data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-ltd='false' data-dcm-app-id=''> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins><img src='https://rtb.adentifi.com/Imps?impId=1;adId=fd181b52-b40f-11f0-a366-1249d22f96b3;lId=103491;sId=772807;cId=19716;crId=490149;adThdId=d40443e7ac16c6af7659e34a6130da83;adExchange=BidSwitch;engineId=i-01fe4a2c5dab46173;dealId=0;geoId=111875;inventoryId=223217;rtdmIndicator=1;timestamp=1761664121;property=dailymail.co.uk;dIp=NTAuMTcwLjIwMC40Mg;dIpv6=;adThdIdCode=WEB_MD5_V4;thirdPartyIdType=1;npiKey=6681098376342481253;hhId=256271813;cuid=cuid_c5040440-d360-11ee-9a9b-125335d52042' style='display:none; width:0px; height:0px;' /><script src="https://tags.bkrtx.com/js/bk-coretag.js"></script><script>bk_addPageCtx("id","cuid_c5040440-d360-11ee-9a9b-125335d52042");bk_allow_multiple_calls = true;bk_use_multiple_iframes = true;bk_send_statid_payload = true;bk_use_image = true;bk_callback = true;bk_doJSTag(18840, 4);</script><span id="te-clearads-js-adtheorent01cont490149"><script type="text/javascript" src="//choices.truste.com/ca?pid=adtheorent01&aid=adtheorent01&cid=19716&c=adtheorent01cont490149&w=300&h=250&js=pmw0&plc=tr&uid=d40443e7ac16c6af7659e34a6130da83"></script></span><img src="https://us-east-sync.bidswitch.net/sync?ssp=kargo&dsp_id=206&imp=1" alt=" " style="display:none"/>Creatives
